Farmers Edge Sees Exercise Of Over-Allotment Option, Bringing IPO Proceeds To $143.8 Million

Farmers Edge (TSX: FDGE) has seen further capital inflows in connection with its initial public offering. The firm this morning announced that it has now received an additional $18.8 million in funds as a result of the full exercise of its over-allotment option that was issued in connection with the financing.

A total of 1.1 million common shares were issued under the over-allotment option, bringing in $18,750,150 in additional funds, with common shares of the issuer sold at a price of $17.00 each. The additional sale brings total gross proceeds from the initial public offering, or IPO, to $143.8 million.

Farmers Edge last traded at $16.47 on the TSX.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Information for this briefing was found via Farmers Edge and Sedar. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Copper Mine Costs 1/6 to Restart | SSR Mining X Roxmore

Why Cambria Hit Pause on Its Massive Copper-Gold Spinout

Can Gold Rescue Washington From Its Debt Trap? | Andy Schectman – Miles Franklin

Recommended

Mercado Minerals Lengthens El Triunfo Vein by 190 Metres, Readies 1,500-Metre Zamora Drill Program

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Related News

Ex-Sony Entertainment CEO-Led Gaming SPAC PowerUp Acquisition Prices Upsized US$250 Million IPO

Special purpose acquisition company PowerUp Acquisition Corp (Nasdaq: PWUPU) started trading publicly on the Nasdaq...

Friday, February 18, 2022, 02:26:00 PM

SpaceX Employees Pool $20B in Equity to Squeeze Wealth Managers on Fees Before IPO

A group of SpaceX employees have organized into a collective bargaining bloc, pooling an estimated...

Tuesday, June 2, 2026, 04:37:29 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

SPAC Lakeshore Acquisition II Prices US$60 Million IPO

Special purpose acquisition company Lakeshore Acquisition II Corp. (Nasdaq: LBBBU) started trading publicly on the...

Wednesday, March 9, 2022, 12:06:00 PM

SpaceX Files for Record-Breaking $1.75 Trillion IPO Targeting June Listing

SpaceX, the rocket and satellite giant led by Elon Musk, has confidentially filed for an...

Wednesday, April 1, 2026, 12:13:10 PM